SS-31 (25mg) is a synthetic tetrapeptide (say, 25mg for common research), can act as a mitochondria-targeted antioxidant and a repair agent. It’s used for penetrating cells and binding cardiolipin on the inner surface of the mitochondria, which increases ATP production and reduces reactive oxygen species.
Our SS-31 (25mg) content is built on peer-reviewed scientific literature, clinical trial data, and evidence-based analysis not assumptions or marketing claims. We rely on reputable sources such as indexed biomedical journals and registered clinical studies to ensure accuracy and credibility.
Each statement is carefully aligned with published findings on mitochondrial function, oxidative stress, and cardiolipin interaction, which are the primary mechanisms studied for SS-31. We avoid overstating outcomes and clearly distinguish between preclinical results, early human trials, and confirmed clinical evidence.
This ensures the information you read is research-driven, verifiable, and responsibly presented, helping you make informed decisions based on science—not speculation.
Core Function: It repairs the damaged mitochondria, reduces oxidative stress and also stabilizes and reduces oxidative stress.
Potential Therapeutic Uses: Research has indicated that it may be useful for treating many conditions linked to mitochondrial dysfunction, including heart failure, ischemia reperfusion, ageing-related pathologies and kidney disease.
Unique Action: Unlike the antioxidants, the SS-31 Peptide can accumulate within the inner mitochondrial membrane.
Status: It’s used currently in clinical trials for many conditions, including primary mitochondrial myopathy and the ophthalmological disease of dry eyes.
Mitochondrial Protection: It inhibits the mitochondrial swelling and the apoptosis that is caused by oxidative stress.
Energy Optimization: It improves the efficiency and the ATP synthesis required for brain health and heart conditions.
Application: It’s highly studied for improving conditions like glaucoma and traumatic brain injury.
Cardiolipin Stabilization: The SS-31 can bind to the cardiolipin in the IMM and promotes the electron carrier functions, which will later stabilize the mitochondrial cristae, preventing degradation.
ROS Reduction: It can act as a potent antioxidant, later decreases the mitochondrial reactive oxygen species, reducing cardiolipin and electron leakage.
ATP Production Enhancement: By protecting the mitochondrial cristae and facilitating the electron transfer between complex 3 and 4, the SS31 can promote mitochondrial respiration and ATP synthesis.
Inhibition of mPTP Opening: SS-31 can stop the mitochondrial permeability transition under various conditions, like stress, preventing cytochorm and mitigating apoptosis, etc.
Pregnant or Breastfeeding Women: Because of low safety data on the fetus or infants, SS-31 can not be contraindicated in such a population.
Individuals with a History of Cancer: SS-31 can improve mitochondrial function and cellular energy, and there’s a theoretical concern that it can support the survival of cancer cells or even increase the risk of recurrence.
Those Seeking Self-Prescribed: It’s a research chemical, so its uses should be supervised by a medical professional only, especially for complete medical histories.
Active Infections/Severe Inflammation: Although it’s anti-inflammatory, SS-31 hasn’t been studied for safety or even severe acute infections.
Long Usage: its treatment can last longer, say about 4 weeks and might not have been roughly studied for long-term safety if not established.
SS-31 (25mg) has scientific significance for its targeted approach in various areas like mitochondrial functions, which are closely related to cellular health and the ageing process. The early findings are highly promising, especially in controlled laboratory and clinical settings. The evidence regarding this is still evolving.
It’s highly important to view the SS-31 through the research first lens, and it should not be confirmed as a therapeutic effect. The studies are exploring its potential across various conditions, especially when there’s no broad or clinical approval for general use; the long-term outcomes are still under investigation.
Physical Appearance: It’s correctly reconstituted an dthats why it appears clear and free from any visible particulate matter.
Environmental Sensitivity: The peptide is highly sensitive to environmental factors such as heat and light. You can maintain the integrity of the solutions and how they should be refrigerated and protected from direct sunlight exposure.
Handling Considerations: In various research settings, the localized reaction, especially at the application site, can have minor discomfort and how it should be documented.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/
https://www.sciencedirect.com/science/article/abs/pii/S1567724924000047
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0315473
https://www.mdpi.com/1422-0067/26/7/3327
https://www.journalofsurgicalresearch.com/article/S0022-4804(10)01233-3/abstract
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.707006/full
Dr Parker is a molecular biologist; she specialises in therapeutic and regenerative medicine. With almost 10 years of experience in peptide research, Dr Parker has contributed to research on cellular health and muscle recovery.